Zelluna ASA (OSL:ZLNA)

Norway flag Norway · Delayed Price · Currency is NOK
14.31
+0.11 (0.79%)
Feb 3, 2026, 9:33 AM CET
Market Cap373.03M
Revenue (ttm)53.00K
Net Income-122.19M
EPS-30.91
Shares Out26.27M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume776
Average Volume15,103
Open14.20
Previous Close14.20
Day's Range14.20 - 14.31
52-Week Range8.20 - 22.50
Betan/a
RSI65.13
Earnings DateFeb 12, 2026

About Zelluna ASA

Zelluna ASA develops T-cell receptor (TCR) cellular immunotherapy products for the treatment of solid cancers. The company was founded in 2016 and is based in Oslo, Norway. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2016
Employees 26
Stock Exchange Oslo Børs
Ticker Symbol ZLNA
Full Company Profile

Financial Performance

Financial Statements

News

Zelluna ASA (OSL:ZLNA) Q3 2025 Earnings Call Highlights: Strategic Advances and Financial Insights

Zelluna ASA (OSL:ZLNA) Q3 2025 Earnings Call Highlights: Strategic Advances and Financial Insights

3 months ago - GuruFocus

Q3 2025 Zelluna ASA Earnings Call Transcript

Q3 2025 Zelluna ASA Earnings Call Transcript

3 months ago - GuruFocus